RE: take me to 1522 Nov 2018 10:01
So I crunched some figures.
Lansdowne Partners fell below the 5% threshold on 26th September. It is impossible to know whether that meant they have 0% left, 4.99% left, or any value inbetween.
80.58 share in issue means would mean a maximum of 4.029m left.
There has been sales volume of between 3m and 3.5m share sold (depending how you treat the 500k unknown from 14th November) making various assumptions on what is a sell and buy. Of this volume, I believe 2.5-3m has been institutional selling (larger trades that are rounded numbers).
I guess everyone has to decide for themselves if the above means Lansdowne are clear now.
It is reassuring to see the selling has stopped, at least for now. A few more days without drift, or a positive finish on any given day and the buying will creep back in. I think there will be a lot of people currently invested, people who used to be invested who still follow it, and new people who have followed it for a while waiting to get back in. The only thing that stopped me buying anymore was the rate of decline, effectively taking a gamble that the price would fall further before I took a new position.
Big seller aside, this was never a bad buy, and the investment case looks incredibly strong now:
Market cap at only £16m.
Announced £20.9m new contracts in the last month alone.
"Currently negotiating a high number of contracts" (RNS 20th Sep).
HVO to turn profitable and generate cash from its operations in 2019.
Positive Preliminary results for AGS-v
Positive results to take Flu-v all the way to phase III
I think all we are lacking is good PR - Trevor Phillips is just the sort of man you want leading a Pharma, but probably just the sort of man you don't want leading all the interviews in terms of passion or charisma.